Philippines approves Pfizer-BioNTech vaccine for emergency use

The Pfizer-BioNTech vaccine, which has shown a 95% success rate, is the first vaccine the Philippines has approved

  
A vial of the Pfizer-BioNTech COVID-19 vaccine is seen at "Chez Mauricette" coronavirus disease vaccination center in Poissy near Paris, France, January 13, 2021.

A vial of the Pfizer-BioNTech COVID-19 vaccine is seen at "Chez Mauricette" coronavirus disease vaccination center in Poissy near Paris, France, January 13, 2021.

Reuters/Gonzalo Fuentes

MANILA: The Philippines' Food and Drug Administration has authorized the emergency use of Pfizer Inc and BioNTech SE's COVID-19 vaccine, its head said on Thursday.

The Pfizer-BioNTech vaccine, which has shown a 95% success rate, is the first vaccine the Philippines has approved.

FDA head Rolando Enrique Domingo told a media briefing China's Sinovac Biotech Ltd on Wednesday submitted to regulators its emergency use authorization application.

(Reporting by Karen Lema Editing by Ed Davies) ((karen.lema@thomsonreuters.com; +632 841-8938;))

More From Health